Whole-genome Sequencing Reveals Distinct Genetic Bases for Insulinomas and Non-Functional Pancreatic Neuroendocrine Tumours: Leading to a New Classification System
Xiafei Hong,Sitan Qiao,Fuqiang Li,Wenze Wang,Rui Jiang,Huanwen Wu,Hao Chen,Lulu Liu,Junya Peng,Jing Wang,Congwei Jia,Xiaolong Liang,Hongmei Dai,Jialin Jiang,Taiping Zhang,Quan Liao,Menghua Dai,Lin Cong,Xianlin Han,Dan Guo,Zhiyong Liang,Dongjing Li,Zetian Zheng,Chen Ye,Siliang Li,Yupei Zhao,Kui Wu,Wenming Wu
DOI: https://doi.org/10.1136/gutjnl-2018-317233
IF: 24.5
2019-01-01
Gut
Abstract:ObjectiveInsulinomas and non-functional pancreatic neuroendocrine tumours (NF-PanNETs) have distinctive clinical presentations but share similar pathological features. Their genetic bases have not been comprehensively compared. Herein, we used whole-genome/whole-exome sequencing (WGS/WES) to identify genetic differences between insulinomas and NF-PanNETs.DesignThe mutational profiles and copy-number variation (CNV) patterns of 211 PanNETs, including 84 insulinomas and 127 NF-PanNETs, were obtained from WGS/WES data provided by Peking Union Medical College Hospital and the International Cancer Genome Consortium. Insulinoma RNA sequencing and immunohistochemistry data were assayed.ResultsPanNETs were categorised based on CNV patterns: amplification, copy neutral and deletion. Insulinomas had CNV amplifications and copy neutral and lacked CNV deletions. CNV-neutral insulinomas exhibited an elevated rate ofYY1mutations. In contrast, NF-PanNETs had all three CNV patterns, and NF-PanNETs with CNV deletions had a high rate of loss-of-function mutations of tumour suppressor genes. NF-PanNETs with CNV alterations (amplification and deletion) had an elevated risk of relapse, and additionalDAXX/ATRXmutations could predict an increased relapse risk in the first 2-year period.ConclusionThese WGS/WES data allowed a comprehensive assessment of genetic differences between insulinomas and NF-PanNETs, reclassifying these tumours into novel molecular subtypes. We also proposed a novel relapse risk stratification system using CNV patterns andDAXX/ATRXmutations.